Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy

Cardiovasc Revasc Med. 2008 Jul-Sep;9(3):179-81. doi: 10.1016/j.carrev.2007.06.003.

Abstract

Stent thrombosis is a rare but serious complication of percutaneous coronary intervention. Stent thrombosis usually occurs early after stent implantation but can occasionally occur late, especially when drug-eluting stents are used. We report a case of recurrent late paclitaxel-eluting stent thrombosis (8 and 21 months after initial stent implantation) upon discontinuation of dual antiplatelet therapy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Coronary Angiography
  • Coronary Thrombosis / diagnosis
  • Coronary Thrombosis / etiology*
  • Coronary Thrombosis / surgery
  • Drug-Eluting Stents*
  • Electrocardiography
  • Follow-Up Studies
  • Graft Occlusion, Vascular / diagnosis
  • Graft Occlusion, Vascular / etiology*
  • Graft Occlusion, Vascular / surgery
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction / drug therapy
  • Myocardial Infarction / surgery*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Recurrence
  • Thrombectomy
  • Ultrasonography, Interventional

Substances

  • Platelet Aggregation Inhibitors